Literature DB >> 4262519

Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.

Y Takeda, T R Parkhill, M Nakabayashi.   

Abstract

The isotopic method described previously for quantification of plasmin- (125)I by disc gel electrophoresis was modified by inclusion of euglobulin precipitation to expand its applicability to plasmas containing low radioactivity of plasmin- (125)I and plasminogen- (125)I. It was found that the euglobulin precipitation method precipitates 72.4+/-2.1 (sd)% of both plasmin- (125)I and plasminogen- (125)I. Using this method and plasminogen- (125)I as a tracer, studies were first made of the effects of heparin and epsilon-aminocaproic acid in dogs on plasmin- (125)I generation in responese to a single injection of urokinase and to venous injury; second, of the effects of venous occlusion and thrombosis on plasmin- (125)I generation; and third, in vitro studies of plasminogen- (125)I affinity to fibrin and its activation in blood clots. The venous injury was produced by the damage of venous endothelium by an injection of 90% phenol and the thrombosis by a thrombin injection into an occluded vein. Heparin and epsilon-aminocaproic acid under the present experimental conditions inhibited about 78 and 100%, respectively of plasmin- (125)I generation by the urokinase injection. Similar inhibitory effects of heparin and epsilon-aminocaproic acid were observed on plasmin- (125)I generation in response to venous injury. The venous occlusion caused a small degree of plasmin- (125)I generation, but thrombin thrombosis did not seem to stimulate the generation of plasmin- (125)I. The in vitro studies showed that plasminogen- (125)I does not have a specific affinity to fibrin and is incorporated into blood clots in approximately equal concentrations as those in serum during clotting processes, and that blood clots per se do not stimulate plasmin- (125)I generation. These results suggest that injured veins release considerable amounts of vascular plasminogen activators into circulation and that these play an important role in thrombus dissolution in vivo.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4262519      PMCID: PMC332967          DOI: 10.1172/JCI107086

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  INTERACTION OF HEPARIN WITH FIBRINOLYSIS.

Authors:  R HOLEMANS; D ADAMIS; J F HORACE
Journal:  Thromb Diath Haemorrh       Date:  1963-07-15

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  THE ASSAY OF UROKINASE PREPARATIONS FOR CONTAMINATION WITH THROMBOPLASTIC MOIETIES.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Lab Clin Med       Date:  1965-05

4.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

5.  Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin.

Authors:  H LACKNER; C MERSKEY
Journal:  Br J Haematol       Date:  1960-10       Impact factor: 6.998

6.  The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma.

Authors:  Y KONTTINEN
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

7.  [Effect of thrombin and heparin on fibrinolysis].

Authors:  E EICHENBERGER
Journal:  Experientia       Date:  1952-09-15

8.  Proteolytic enzymes in blood.

Authors:  T ASTRUP; J CROOKSTON; A MACINTYRE
Journal:  Acta Physiol Scand       Date:  1950-11

9.  Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.

Authors:  Y Takeda
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

10.  Studies on the purification and activation of plasminogen (profibrinolysin).

Authors:  D L KLINE
Journal:  Yale J Biol Med       Date:  1954-04
View more
  2 in total

1.  Physicochemical and biological properties of human and canine plasmins.

Authors:  Y Takeda; M Nakabayashi
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

2.  Urine plasmin-like substances as an index of kidney allograft rejections.

Authors:  K Fukao; N Kashiwagi; T Kajiwara; M Ishikawa; B Husberg; R Weil; T E Starzl
Journal:  Transplantation       Date:  1977-05       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.